Effectiveness of triamcinolone in suprascapular nerve block for adhesive capsulitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0002926

Enrollment

Registered

2018-06-15

Start date

2018-06-29

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Randomization with two group and perfoming suprascapular nerve block

? group of suprascapular nerve block with steroid: 8ml of 1&#37

bupivacaine and 2 mL of 10 mg/mL triamcinolone acetonide, ? group of suprascapular nerve block without steroid: 8 mL of 1&#37

bupivacane only

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Age 19 to 75 years old (2) Adhesive capsulitis for at least 1 month of pain duration: restriction of passive motion of greater than 30° in two or more planes of movement.

Exclusion criteria

Exclusion criteria: (1) Secondary adhesive capsulitis (2) Definite rotator cuff lesion; complete or full-thickness tear of the rotator cuff (3) High-risk bleeding tendency (4) Previous history of shoulder surgery

Design outcomes

Primary

Measure	Time frame
visual analog scale	—

Secondary

Measure	Time frame
SPADI(shoulder pain and disability index);Passive range of motion of shoulder;number of ingestion of oral analgesics per day	—

Countries

Korea, Republic of

Contacts

Public ContactYoung chun Yoon

Ajou University Hospital

homcar@naver.com+82-31-219-5507

Outcome results